Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, 1994-2009

International Journal of Infectious Diseases

Volumn 16, Issue 7, 2012, Pages

  Campello Porto, Liú ^a   Duarte, Elisabeth Carmen ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Classification of Lebech; Congenital toxoplasmosis; Risk factors; Toxoplasmosis in the pregnant woman; Toxoplasmosis treatment

Indexed keywords

ARTICLE; BRAZIL; CHILD; COHORT ANALYSIS; CONGENITAL TOXOPLASMOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HIGH RISK PREGNANCY; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; PREGNANCY TOXOPLASMOSIS; PREGNANT WOMAN; PRENATAL CARE; PRESCHOOL CHILD; TOXOPLASMOSIS;

BRAZIL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOGISTIC MODELS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL CARE; RISK FACTORS; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 84862539426     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.01.016     Document Type: Article

References (33)

1. Jara M., Hsu H.W., Eaton J., Demaria A. Epidemiology of congenital toxoplasmosis identified by population-based newborn screening in Massachusetts. Pediatr Infect Dis J 2001, 20:1132-1135.
2. Avelino M.M., Campos D., Parada J., Castro A.M. Risk factors for Toxoplasma gondii infection in women of childbearing age. Braz J Infect Dis 2004, 8:164-174.
3. Hill D., Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002, 8:634-640.
4. Caiaffa W.T., Chiari C.A., Figueiredo A.R., Orefice F., Antunes C.M. Toxoplasmosis and mental retardation-report of case control study. Mem Inst Oswaldo Cruz 1993, 88:253-261.
5. Reis M.M., Tessaro M.M., D'Azevedo P.A. Toxoplasma-IgM and IgG-avidity in single samples from areas with a high infection rate can determine the risk of mother-to-child transmission. Rev Inst Med Trop Sao Paulo 2006, 48:93-98.
6. Pinard J.A., Irvine P.J. Maternal serologic screening for toxoplasmosis. J Midwifery Womens Health 2003, 48:308-316.
7. Manual de toxoplasmose gestacional e congênita. Brasília, FD: State Health Secretariat; 2010.
8. Lebech M., Joynson D.H., Seitz H.M., Thulliez P., Gilbert R.E., Dutton G.N., et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Microbiol Infect Dis 1996, 15:799-805.
9. Wallon M., Liou C., Garner P., Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999, 318:1511-1514.
10. Foulon W., Villena I., Stray-Pedersen B., Decoster A., Lappalainen M., Pinon J.M., et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact of fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999, 180:410-415.
11. Gilbert R.E., Gras L., Wallon M., Peyron F., Ades A.E., Dunn D.T. Effect of prenatal treatment on mother to child transmission of T. gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 2001, 30:1303-1308.
12. Gilbert R.E., Gras L. European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003, 110:112-120.
13. Jones J., Lopez A., Wilson M. Congenital toxoplasmosis. Am Fam Physician 2003, 67:2131-2138.
14. Montoya J.G., Rosso F. Diagnosis and management of toxoplasmosis. Clin Perinatol 2005, 32:705-726.
15. Boyer K.M., Holfels E., Roizen N., Swisher C., Mack M., Remington J., et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol 2005, 192:564-571.
16. Elsheika H.M. Congenital toxoplasmosis: priorities for further health promotion action. Public Health 2008, 122:335-353.
17. The SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 2007;369:115-22.
18. StataCorp. Stata statistical software: release 10. College Station, TX: StataCorp LP; 2007.
19. Martin F. Congenital toxoplasmosis: value of antenatal screening and current prenatal treatment. Neonatal Netw 2001, 20:23-30.
20. Mozzatto L., Procianoy R. Incidence of congenital toxoplasmosis in southern Brazil: a prospective study. Rev Inst Med Trop Sao Paulo 2003, 45:147-151.
21. Barreto S.M., Costa J.C., Gonçalves A.L. Pesquisa de anticorpos para sífilis e toxoplasmose em recém-nascidos em Hospital de Ribeirão Preto, SP, Brasil. Rev Saude Publica 1987, 21:55-63.
22. Lago E.G., Carvalho R.L., Jungblut R., Silva V.B., Fiori R.M. Screening for Toxoplasma gondii antibodies in 2,513 consecutive parturient women and evaluation of newborn infants at risk for congenital toxoplasmosis. Scientia Medica 2009, 19:27-34.
23. Durlach R., Kaufer F., Carral L., Freuler C., Ceriotto M., Rodriguez M., et al. Consenso Argentino de Toxoplasmose Congénita. Medicina (B Aires) 2008, 68:75-87.
24. Mombrò M., Perathoner C., Leone A., Buttafuoco V., Zotti C., Lievre M.A., et al. Congenital toxoplasmosis: assessment of risk to newborns in confirmed and uncertain maternal infection. Eur J Pediatr 2003, 162:703-706.
25. Dunn D., Wallon M., Peyron F., Petersen E., Peckham C., Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999, 353:1829-1833.
26. Flori P., Bellete B., Crampe C., Maudry A., Patural H., Chauleur C., et al. A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti-Toxoplasma IgG avidity test. Clin Microbiol Infect 2008, 14:242-249.
27. Lopez A., Dietz V.J., Wilson M., Navin T.R., Jones J.L. Preventing congenital toxoplasmosis. MMWR Recomm Rep 2000, 49(RR-2):59-68.
28. Gras L., Wallon M., Pollak A., Cortina-Borja M., Evengard B., Hayde M., et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Pediatr 2005, 94:1721-1731.
29. Londrina manual of gestational and congenital toxoplasmosis. Londrina, Paraná, Brazil: State Health Secretariat of Londrina; 2010.
30. Remington J.S., Klein J. Infectious diseases of the fetus and newborn infant 2006, WB Saunders, Co., Philadelphia, p. 229-31. 5th ed.
31. Kieffer F., Thulliez P., Kassis M., Rigourd V., Magny J.F. [Prenatal treatment for congenital toxoplasmosis] (in French). Arch Pediatr 2009, 16:885-887.
32. Castilho-Pelloso M.P., Falavigna D.L., Falavigna-Guilherme A.L. Suspected acute toxoplasmosis in pregnant women. Rev Saude Publica 2007, 41:27-34.
33. Couto J.C., Melo R.N., Rodrigues M.V., Leite J.M. Diagnóstico pré-natal e tratamento da toxoplasmosena gestação. Femina 2003, 31:85-90.